Čeština | Dansk | Deutsch | English | Español | Français | Italiano | Nederlands | Norsk | Polski | Português | Pусский | Suomi | Svenska | US
Euro Huntington's disease network [logo]
Programme III -
Sunday, September 16th, 2012
Breakfast teaching courses
08:00-09:30   Drug discovery and development process
Seung Kwak (Princeton, USA)
08:00-09:30   Training on HD assessments including HD-CC
David Craufurd (Manchester, UK), Ralf Reilmann (Münster, Germany), Jennifer Thompson (Manchester, UK), Oliver Quarrell (Sheffield, UK)
08:00-09:30   HD for Basic Scientists
G. Bernhard Landwehrmeyer (Ulm, Germany)
08:00-09:30   Common issues/problems/inconsistencies in HD assessments
Joaquim Ferreira (Lisbon, Portugal), Michael Orth (Ulm, Germany)
09:30-10:00   Tea/Coffee Break

Plenary Session IX:
Scientific presentations - 'Tools and outcome to monitor disease progression and response to therapy'

Chair: Sheila Simpson (Aberdeen, UK)
10:00-12:00   Parallel Session: EHA Business Meeting for EHA members
Room Millesrummet
10:00-10:20   Brain imaging as a potential marker for HD (PET & MRI)
PET - Andrea Varrone (Stockholm, Sweden)
MRI - Rachael Scahill (London, UK)
10:20-10:40   Defining predictors of disease
Sarah Tabrizi (London, UK)
10:40-11:00   New assessment tools (cognitive batteries)
Julie Stout (Melbourne, Australia), Anne-Catherine Bachoud-Lévi (Créteil, France)
11:00-11:30   REGISTRY and Enroll-HD
G. Bernhard Landwehrmeyer (Ulm, Germany)
11:30-12:00   Poster Awards
Roundup III
12:00-12:30   Charles Sabine: Progress in HD research and HD advocacy: a personal view

Meeting Adjourn/Closing Remarks
Afternoon programme
14:00-18:00   Social Activities

EHA meeting